Kezar Life Sciences, Inc

(NASDAQ:KZR)

Latest On Kezar Life Sciences, Inc (KZR):

Date/Time Type Description Signal Details
2023-05-11 21:39 ESTNewsKezar Life Sciences GAAP EPS of -$0.31N/A
2023-03-16 19:59 ESTNewsKezar sheds 14% after R&D event as William Blair downgradesN/A
2023-03-14 22:26 ESTNewsKezar Life Sciences GAAP EPS of -$0.25 beats by $0.03N/A
2022-11-16 14:05 ESTNewsKezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Reduce To HoldN/A
2022-11-10 19:10 ESTNewsKezar Life Sciences GAAP EPS of -$0.25N/A
2022-10-04 03:26 ESTNewsFDA clears Kezar Life Sciences' drug application for autoimmune hepatitis treatmentN/A
2022-08-12 04:34 ESTNewsKezar Life Sciences GAAP EPS of -$0.25 beats by $0.02N/A
2022-07-27 20:58 ESTNewsKezar Life Sciences: Regulatory Tailwinds Reverse Downside CaseN/A
2022-07-11 21:41 ESTNewsKezar Life Sciences appoints Nick Mordwinkin as chief business officerN/A
2022-06-29 01:14 ESTNewsKezar climbs 83% after mid-stage data for lupus nephritis candidateN/A
2022-06-29 01:14 ESTNewsKezar rises 92% after mid-stage data for lead asset in lupus nephritisN/A
2022-06-28 05:57 ESTNewsKezar climbs ~83% after mid-stage data for lupus nephritis candidateN/A
2022-05-12 19:35 ESTNewsKezar Life Sciences GAAP EPS of -$0.26 beats by $0.02N/A
2022-05-03 16:59 ESTNewsKezar Life Sciences crashes after setback to lead asset in mid-stage trialN/A
2022-03-24 15:52 ESTNewsKezar Life Sciences climbs after over $1 million insider purchaseN/A
2022-03-19 00:06 ESTNewsKezar Life Sciences GAAP EPS of -$1.04N/A
2021-11-16 23:25 ESTNewsKezar Life extends rally as analysts highlight data for kidney disease therapyN/A
2021-11-16 03:35 ESTNewsKezar Life Sciences rises 66% on phase 2 data for lupus candidateN/A
2021-10-27 21:09 ESTNewsKezar Life Sciences gets dosing underway in early-stage KZR-261 trialN/A
2021-09-10 23:56 ESTNewsKezar Life Sciences (KZR) Corporate OverviewN/A
2021-08-23 11:04 ESTNewsKezar Life Sciences completes enrollment in mid-stage polymyositis trialN/A
2021-08-12 19:50 ESTNewsKezar Life Sciences EPS beats by $0.01N/A
2021-03-16 21:15 ESTAnalyst RatingThe Analyst Target Price has increased from $14.67 to $15.Buy
2021-03-14 09:00 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 11:54 ESTEarnings EstimateAn EPS average of -$1.18 is estimated for the 2022 year.Sell
2021-03-12 11:54 ESTEarnings EstimateAn EPS average of -$0.27 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-12 08:00 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 06:21 ESTNewsKezar Life Sciences reports Q4 resultsN/A
2021-01-29 02:48 ESTNewsKezar Life Sciences: Targeting The Immunoproteasome To Treat AutoimmunityN/A
2021-01-06 16:01 ESTFinancialsCompany financials have been released.Neutral
2020-12-14 21:07 ESTNewsKezar Life Sciences selected for the Nasdaq Biotechnology IndexN/A
2020-11-26 20:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 12:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 12:25 ESTNewsKezar Life Sciences EPS misses by $0.02N/A
2020-11-06 12:24 ESTNewsKezar Life Sciences: Keyed In On Autoimmune TherapiesN/A
2020-11-06 08:15 ESTEarnings EstimateAn EPS average of -$0.24 is estimated for the quarter ending on March 31, 2021.Sell
2020-10-24 03:59 ESTNewsKezar Life Sciences' KZR-616 an Orphan Drug in U.S. for autoimmune inflammatory disordersN/A
2020-09-26 13:14 ESTFinancialsCompany financials have been released.Neutral
2020-09-18 09:35 ESTNewsEncouraging lupus data lifts Kezar Life Sciences, up 9% after hoursN/A
2020-09-17 05:20 ESTFinancialsCompany financials have been released.Neutral
2020-09-07 13:41 ESTNewsKezar Life Sciences: Exploring New Options For Autoimmune DiseasesN/A
2020-08-14 09:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 09:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 09:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 17:49 ESTNewsKezar Life Sciences, Inc. (KZR) CEO John Fowler on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-07 17:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.33 to $14.67.Neutral
2020-08-07 09:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 20:44 ESTNewsKezar Life Sciences, Inc. 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-05 17:51 ESTNewsKezar Life Sciences EPS beats by $0.04N/A

About Kezar Life Sciences, Inc (KZR):

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is based in South San Francisco, California.

KZR Quotes by TradingView

See Advanced Chart

General

  • Name Kezar Life Sciences, Inc
  • Symbol KZR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 47
  • Fiscal Year EndDecember
  • IPO Date2018-06-21
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.kezarlifesciences.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.14
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.00
  • Next Year EPS Estimate -$1.23
  • Next Quarter EPS Estimate -$0.25
  • Return on Assets -22%
  • Return on Equity -38%
  • Earnings Per Share -$1.46
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 292.24 million
  • EBITDA -29317000
  • Analyst Target Price $15
  • Book Value Per Share $3.04
View More

Share Statistics

  • Shares Outstanding 48.07 million
  • Shares Float 33.4 million
  • % Held by Insiders 3166%
  • % Held by Institutions 54.59%
  • Shares Short 1.76 million
  • Shares Short Prior Month 1.68 million
  • Short Ratio 6.2
  • Short % of Float 5%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 0.33
  • 52 Week High $7.15
  • 52 Week Low $3.43
  • 50 Day Moving Average 5.9
  • 200 Day Moving Average 5.51
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Kezar Life Sciences, Inc (KZR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Kezar Life Sciences, Inc (KZR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.22-$0.234.35%
2020-09-302020-11-05$N/A-$0.23-$0.21-8.24%
2020-06-302020-08-05$N/A-$0.22-$0.2716.98%
2020-03-312020-05-07$N/A-$0.30-$0.3922.08%
2019-12-312020-03-12$N/A-$0.50-$0.524.45%
2019-09-302019-11-06$N/A-$0.48-$0.515.42%
2019-06-302019-08-07$N/A-$0.46-$0.484.17%
2019-03-312019-05-07$N/A-$0.40-$0.424.01%
2018-12-312019-03-26$N/A-$0.30-$0.4532.84%
2018-09-302018-11-08$N/A-$0.30-$0.5040.39%
2018-06-302018-08-09$N/A-$0.51-$0.568.93%

Kezar Life Sciences, Inc (KZR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Kezar Life Sciences, Inc (KZR) Chart:

KZR chart by TradingView

Kezar Life Sciences, Inc (KZR) News:

Below you will find a list of latest news for Kezar Life Sciences, Inc (KZR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Kezar Life Sciences, Inc (KZR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL5 38384.72FALSE0.050
2024-05-1750.05CALL0 100FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 00TRUE00
2024-05-1750PUT0 00TRUE00
2024-05-177.50PUT0 00TRUE00
2024-06-212.50CALL0 00FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 00TRUE00
2024-06-2150PUT0 0308.65TRUE00
2024-06-217.50PUT0 00TRUE00
2024-07-192.50.1CALL0 670FALSE00
2024-07-1950CALL0 00FALSE00
2024-07-197.50.12CALL0 120FALSE00
2024-07-192.51.6PUT0 10TRUE00
2024-07-1950PUT0 0257.32TRUE00
2024-07-197.50PUT0 00TRUE00
2024-10-182.50.1CALL0 78147.95FALSE00
2024-10-1850.45CALL0 10FALSE00
2024-10-187.50CALL0 00FALSE00
2024-10-182.50PUT0 00TRUE00
2024-10-1850PUT0 0191.37TRUE00
2024-10-187.50PUT0 00TRUE00
2025-01-172.50.1CALL0 534128.65FALSE00
2025-01-1750.48CALL0 440FALSE00
2025-01-177.50.1CALL0 290FALSE00
2025-01-17100.25CALL0 260FALSE00
2025-01-1712.50.1CALL0 10FALSE00
2025-01-17150.1CALL0 60FALSE00
2025-01-1717.50.2CALL0 860FALSE00
2025-01-172.51.8PUT0 9136.42TRUE00
2025-01-1750PUT0 0227.21TRUE00
2025-01-177.50PUT0 0240.01TRUE00
2025-01-17100PUT0 0242.62TRUE00
2025-01-1712.50PUT0 0261.18TRUE00
2025-01-17150PUT0 0277.08TRUE00
2025-01-1717.50PUT0 0313.66TRUE00

Latest KZR Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST102$4.595
Jun 13, 2022 7:59 PM EST100$4.6
Jun 13, 2022 7:59 PM EST100$4.605
Jun 13, 2022 7:59 PM EST15$4.605
Jun 13, 2022 7:59 PM EST800$4.61

Kezar Life Sciences, Inc (KZR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039131/0001209191-20-039131-index.htm
2019-07-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1645666/000000000019010880/0000000000-19-010880-index.htm
2020-09-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1645666/000000000020008833/0000000000-20-008833-index.htm
2018-08-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000031506618002173/0000315066-18-002173-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000031506619001116/0000315066-19-001116-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000031506620001074/0000315066-20-001074-index.htm
2020-03-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000031506620001354/0000315066-20-001354-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000087257418000003/0000872574-18-000003-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000089924318017995/0000899243-18-017995-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000089924318018026/0000899243-18-018026-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000092189520000331/0000921895-20-000331-index.htm
2018-07-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000092963818000617/0000929638-18-000617-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000092963819000275/0000929638-19-000275-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000092963820000327/0000929638-20-000327-index.htm
2018-07-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000093583618000407/0000935836-18-000407-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000093583619000114/0000935836-19-000114-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000093583620000137/0000935836-20-000137-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000110465919008265/0001104659-19-008265-index.htm
2019-03-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000110465919016793/0001104659-19-016793-index.htm
2019-05-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000110465919031736/0001104659-19-031736-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000110465920011907/0001104659-20-011907-index.htm
2020-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000110465920011910/0001104659-20-011910-index.htm
2020-02-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1645666/000110465920021738/0001104659-20-021738-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000110465920073387/0001104659-20-073387-index.htm
2020-06-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1645666/000110465920073767/0001104659-20-073767-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000114036118030192/0001140361-18-030192-index.htm
2018-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000114420418035610/0001144204-18-035610-index.htm
2018-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000114420418035616/0001144204-18-035616-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000114420418035850/0001144204-18-035850-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000114420418035852/0001144204-18-035852-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000117911018009105/0001179110-18-009105-index.htm
2018-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1645666/000119312518198518/0001193125-18-198518-index.htm
2018-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000119312518204228/0001193125-18-204228-index.htm
2019-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000119312519023303/0001193125-19-023303-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000119312519032354/0001193125-19-032354-index.htm
2019-07-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1645666/000119312519189219/0001193125-19-189219-index.htm
2019-07-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1645666/000119312519191257/0001193125-19-191257-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520019618/0001193125-20-019618-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000119312520019638/0001193125-20-019638-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520023094/0001193125-20-023094-index.htm
2020-02-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000119312520023098/0001193125-20-023098-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000119312520028599/0001193125-20-028599-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1645666/000119312520037817/0001193125-20-037817-index.htm
2020-06-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520162649/0001193125-20-162649-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000119312520162653/0001193125-20-162653-index.htm
2020-06-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520163460/0001193125-20-163460-index.htm
2020-06-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520165213/0001193125-20-165213-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000119312520165216/0001193125-20-165216-index.htm
2020-09-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1645666/000119312520244170/0001193125-20-244170-index.htm
2020-09-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1645666/000119312520250154/0001193125-20-250154-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1645666/000119312520252313/0001193125-20-252313-index.htm
2018-06-223/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039347/0001209191-18-039347-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039666/0001209191-18-039666-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039668/0001209191-18-039668-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039670/0001209191-18-039670-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039671/0001209191-18-039671-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039674/0001209191-18-039674-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039676/0001209191-18-039676-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919118039678/0001209191-18-039678-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119002836/0001209191-19-002836-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119002839/0001209191-19-002839-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119002842/0001209191-19-002842-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119002843/0001209191-19-002843-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119017374/0001209191-19-017374-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119017379/0001209191-19-017379-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119039246/0001209191-19-039246-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119039248/0001209191-19-039248-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119039252/0001209191-19-039252-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119039261/0001209191-19-039261-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119039356/0001209191-19-039356-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119042975/0001209191-19-042975-index.htm
2019-07-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119043385/0001209191-19-043385-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119045642/0001209191-19-045642-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119045644/0001209191-19-045644-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119045647/0001209191-19-045647-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119045653/0001209191-19-045653-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119046006/0001209191-19-046006-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119046223/0001209191-19-046223-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119047055/0001209191-19-047055-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119047057/0001209191-19-047057-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119049052/0001209191-19-049052-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119049053/0001209191-19-049053-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119053040/0001209191-19-053040-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119056481/0001209191-19-056481-index.htm
2019-12-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119061330/0001209191-19-061330-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119061346/0001209191-19-061346-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919119061567/0001209191-19-061567-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120003247/0001209191-20-003247-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120003249/0001209191-20-003249-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120003251/0001209191-20-003251-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120003253/0001209191-20-003253-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120007047/0001209191-20-007047-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120007050/0001209191-20-007050-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120007054/0001209191-20-007054-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120007057/0001209191-20-007057-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120007060/0001209191-20-007060-index.htm
2020-05-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120026788/0001209191-20-026788-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120026796/0001209191-20-026796-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120036045/0001209191-20-036045-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039108/0001209191-20-039108-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039110/0001209191-20-039110-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039113/0001209191-20-039113-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039125/0001209191-20-039125-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039128/0001209191-20-039128-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1645666/000120919120039131/0001209191-20-039131-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459018021041/0001564590-18-021041-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459018021052/0001564590-18-021052-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459018028295/0001564590-18-028295-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459018028296/0001564590-18-028296-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019000279/0001564590-19-000279-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019000394/0001564590-19-000394-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019006480/0001564590-19-006480-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019009223/0001564590-19-009223-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1645666/000156459019009369/0001564590-19-009369-index.htm
2019-03-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1645666/000156459019009374/0001564590-19-009374-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1645666/000156459019014003/0001564590-19-014003-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1645666/000156459019014005/0001564590-19-014005-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019016494/0001564590-19-016494-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459019016498/0001564590-19-016498-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019022455/0001564590-19-022455-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019023442/0001564590-19-023442-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019030045/0001564590-19-030045-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459019030063/0001564590-19-030063-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019036385/0001564590-19-036385-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019041029/0001564590-19-041029-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459019041391/0001564590-19-041391-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019042643/0001564590-19-042643-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459019046391/0001564590-19-046391-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020000907/0001564590-20-000907-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020010453/0001564590-20-010453-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1645666/000156459020010498/0001564590-20-010498-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1645666/000156459020010530/0001564590-20-010530-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020016004/0001564590-20-016004-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1645666/000156459020019764/0001564590-20-019764-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1645666/000156459020019777/0001564590-20-019777-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020022845/0001564590-20-022845-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459020022864/0001564590-20-022864-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020028249/0001564590-20-028249-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020030841/0001564590-20-030841-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020036788/0001564590-20-036788-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459020037297/0001564590-20-037297-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1645666/000156459020051298/0001564590-20-051298-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1645666/000156459020051314/0001564590-20-051314-index.htm
2019-07-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1645666/999999999519001575/9999999995-19-001575-index.htm
2020-09-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1645666/999999999520002547/9999999995-20-002547-index.htm
2018-06-21CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1645666/999999999718006519/9999999997-18-006519-index.htm

Kezar Life Sciences, Inc (KZR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kezar Life Sciences, Inc (KZR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3166%
Institutional Ownership: 5459%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-09Marc BelskyCFOBuy500.004.822,410.001,000.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119045642/0001209191-19-045642-index.htm
2019-08-20Marc BelskyCFOBuy200.004.42884.001,200.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119047057/0001209191-19-047057-index.htm
2019-08-09Vassiliki EconomidesSVP, Strategy & External Aff.Buy1,020.004.965,057.361,451.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119045644/0001209191-19-045644-index.htm
2020-02-04Marc BelskyCFOBuy15,384.002.6039,998.4015,384.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120007057/0001209191-20-007057-index.htm
2018-06-25Cormorant Asset Management, LP10% Share HolderBuy250,000.0015.003,750,000.001,572,909.00https://www.sec.gov/Archives/edgar/data/1645666/000114036118030192/0001140361-18-030192-index.htm
2019-08-20Vassiliki EconomidesSVP, Strategy & External Aff.Buy350.004.411,543.571,801.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119047055/0001209191-19-047055-index.htm
2019-11-13Marc BelskyCFOBuy800.002.762,207.042,000.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119056481/0001209191-19-056481-index.htm
2018-06-25Venture Investments Ltd Morningside10% Share HolderBuy250,000.0015.003,750,000.002,309,052.00https://www.sec.gov/Archives/edgar/data/1645666/000120919118039676/0001209191-18-039676-index.htm
2019-08-09John Franklin FowlerCEOBuy500.005.262,627.50293,204.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119045647/0001209191-19-045647-index.htm
2019-08-09John Franklin FowlerCEOBuy750.005.013,761.03293,954.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119045647/0001209191-19-045647-index.htm
2019-08-13John Franklin FowlerCEOBuy2,000.004.669,310.00295,954.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119046006/0001209191-19-046006-index.htm
2019-10-10John Franklin FowlerCEOBuy1,000.003.243,235.40296,954.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119053040/0001209191-19-053040-index.htm
2019-08-09Christopher J. KirkPresident and CSOBuy5,000.004.9724,830.00297,934.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119045653/0001209191-19-045653-index.htm
2019-08-13Christopher J. KirkPresident and CSOBuy5,000.004.6123,040.00302,934.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119046223/0001209191-19-046223-index.htm
2020-02-04Christopher J. KirkPresident and CSOBuy38,461.002.6099,998.60342,609.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120007047/0001209191-20-007047-index.htm
2019-12-19John Franklin FowlerCEOBuy50,000.000.9045,000.00346,954.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119061567/0001209191-19-061567-index.htm
2020-02-04John Franklin FowlerCEOBuy38,461.002.6099,998.6038,461.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120007060/0001209191-20-007060-index.htm
2019-07-22Vassiliki EconomidesSVP, Strategy & External Aff.Buy431.005.822,508.72431.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119042975/0001209191-19-042975-index.htm
2019-07-25Marc BelskyCFOBuy444.005.652,510.38444.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119043385/0001209191-19-043385-index.htm
2019-07-26Marc BelskyCFOBuy56.005.80324.80500.00https://www.sec.gov/Archives/edgar/data/1645666/000120919119043385/0001209191-19-043385-index.htm
2018-06-25FRANKLIN M BERGERDirectorBuy50,000.0015.00750,000.00563,157.00https://www.sec.gov/Archives/edgar/data/1645666/000120919118039668/0001209191-18-039668-index.htm
2020-02-04Venture Investments Ltd Morningside10% Share HolderBuy3,800,000.002.609,880,000.006,109,052.00https://www.sec.gov/Archives/edgar/data/1645666/000110465920011907/0001104659-20-011907-index.htm
2018-06-25BAY CITY CAPITAL LLC10% Share HolderBuy150,000.0015.002,250,000.00622,229.00https://www.sec.gov/Archives/edgar/data/1645666/000117911018009105/0001179110-18-009105-index.htm
2020-06-11Talent Investments Ltd Equal10% Share HolderBuy1,454,545.005.507,999,997.506,254,545.00https://www.sec.gov/Archives/edgar/data/1645666/000110465920073387/0001104659-20-073387-index.htm
2020-02-04FRANKLIN M BERGERDirectorBuy120,846.002.60314,199.60684,003.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120007050/0001209191-20-007050-index.htm
2020-02-04Vassiliki EconomidesSVP, Strategy & External Aff.Buy5,769.002.6014,999.407,570.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120007054/0001209191-20-007054-index.htm
2020-06-11FRANKLIN M BERGERDirectorBuy100,000.005.50550,000.00784,003.00https://www.sec.gov/Archives/edgar/data/1645666/000120919120036045/0001209191-20-036045-index.htm